ADT1129-Cetrelimab Biosimilar-Anti-PDCD1/PD1/CD279 mAb-Research Grade
- +1 609-736-0910
- info@alphalifetech.com
- 90 State Street, STE 700 Office 40, Albany, NY 12207 United States
Product Background
Catalog Number |
ADT1129 |
Product Name |
ADT1129-Cetrelimab Biosimilar-Anti-PDCD1/PD1/CD279 mAb-Research Grade |
Alias |
JNJ-63723283 |
Clonity |
Monoclonal |
|
Alternate Names anti-mouse pd-1 antibody, anti-pd-1 antibody, anti pd-1 antibody, recombinant pd-1, pd-1 antibody, anti-pd-1 monoclonal antibody, pd-1 antibodies, pd-1 recombinant antibody, pd-1 blocking antibody, CD279 recombinant antibody, CD279 blocking antibody |
|
Host |
CHO Cells |
Species |
Human |
Target |
PDCD1/PD-1/CD279 |
Gene ID |
5133 |
Isotype |
IgG4 Kappa |
Size |
1mg, 5mg |
Research Area |
Cancer |
CAS Number |
2050478-92-5 |
Product Description |
Cetrelimab is under investigation in clinical trial NCT03547037 (A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of JNJ-63723283, an Anti-Programmed Cell Death (PD)-1 Monoclonal Antibody, as Monotherapy or in Combination With Erdafitinib in Japanese Participants With Advanced Solid Cancers). |
Application |
Elisa, WB |
Purity |
>95% as determined by SDS-PAGE |
Concentration |
batch dependent |
Buffer |
Supplied in PBS, PH7.5 |
Storage |
Store at -20 °C for 12 months. Store at -80 °C for long term storage. |
Shipping Condition |
Shipped on ice packs. |
Note |
This product is for research use only. |
Reference |
1. Cai J, et al. Immun Inflamm Dis, 2023 May. PMID 37249282
2. Meng FH, et al. Arterioscler Thromb Vasc Biol, 2023 Jul. PMID 37165876
3. Menichelli D, et al. Kardiol Pol, 2023. PMID 36929300
|